HTBX Heat Biologics, Inc. Stock Quote

HTBX [NASD]

Index	-	P/E	-	EPS (ttm)	-2.26	Insider Own	4.40%	Shs Outstand	22.83M	Perf Week	10.95%
Market Cap	161.91M	Forward P/E	-	EPS next Y	-1.19	Insider Trans	-9.08%	Shs Float	21.75M	Perf Month	16.58%
Income	-22.90M	PEG	-	EPS next Q	-0.41	Inst Own	9.60%	Short Float	10.73%	Perf Quarter	-11.33%
Sales	4.30M	P/S	37.65	EPS this Y	33.20%	Inst Trans	6.67%	Short Ratio	2.20	Perf Half Y	-64.08%
Book/sh	5.92	P/B	1.16	EPS next Y	-57.40%	ROA	-36.50%	Target Price	-	Perf Year	237.08%
Cash/sh	4.99	P/C	1.38	EPS next 5Y	-	ROE	-43.70%	52W Range	1.37 - 30.10	Perf YTD	28.54%
Dividend	-	P/FCF	-	EPS past 5Y	49.50%	ROI	-151.80%	52W High	-77.11%	Beta	0.35
Dividend %	-	Quick Ratio	31.30	Sales past 5Y	-	Gross Margin	-	52W Low	404.76%	ATR	0.44
Employees	36	Current Ratio	31.30	Sales Q/Q	13096.60%	Oper. Margin	-	RSI (14)	60.56	Volatility	8.69% 6.23%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	66.50%	Profit Margin	-	Rel Volume	0.76	Prev Close	7.09
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	1.06M	Price	6.89
Recom	2.00	SMA20	14.90%	SMA50	4.63%	SMA200	-11.70%	Volume	803,839	Change	-2.82%

Oct-14-20

Initiated

B. Riley Securities

Buy

Jun-20-16

Initiated

ROTH Capital

Buy

Jan-08-16

Initiated

Noble Financial

Buy

$16

May-26-15

Initiated

H.C. Wainwright

Buy

$13

Sep-18-13

Initiated

Aegis Capital

Buy

$36

Jan-20-21 07:30AM	Heat Biologics CEO to Participate in a Fireside Chat at the B. Riley Securities Oncology Investor Conference on Jan 21, 2021 ACCESSWIRE
Jan-19-21 07:30AM	Heat Biologics Commences Manufacturing Process for ZVX-60 ACCESSWIRE +8.83%
Jan-11-21 08:00AM	Heat Biologics Promotes William L. Ostrander to Chief Financial Officer ACCESSWIRE
Jan-08-21 04:00PM	Heat Biologics to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference ACCESSWIRE
Dec-16-20 07:30AM	Heat Biologics Announces Completion of ZVX-60 Vaccine Cell Line for COVID-19 ACCESSWIRE +9.67%
Dec-10-20 08:00AM	Heat Biologics Provides Business Update ACCESSWIRE -12.31%
Nov-30-20 06:48AM	HTBX: Three Assets in the Clinic Zacks Small Cap Research
Nov-09-20 07:00AM	Heat Biologics Provides Third Quarter 2020 Business Update ACCESSWIRE -9.65%
Oct-30-20 02:40PM	3 Biotech Stocks in the Hunt for COVID-19 Vaccine; One Analyst Calls Them a Buy TipRanks
Oct-28-20 09:33AM	Shareholders Are Thrilled That The Heat Biologics (NASDAQ:HTBX) Share Price Increased 117% Simply Wall St.
Oct-07-20 07:30AM	Heat Biologics Issued Additional Patent on gp96 Combination Platform Therapy with T-cell Co-Stimulator ACCESSWIRE
Sep-16-20 06:37AM	HTBX: Breaking into the Big Leagues: $100 Million + 3 Clinical Candidates Zacks Small Cap Research +23.21%
Sep-09-20 07:30AM	Heat Biologics CEO to Participate in Virtual Panel: "New Approaches to COVID-19: Hidden Breakthroughs," on Thursday, September 10th ACCESSWIRE +5.26%
Sep-02-20 07:30AM	Heat Biologics Issued Key Patent on Combination Platform Therapy ACCESSWIRE
Aug-30-20 12:41PM	Has The COVID-19 Vaccine Stock Bubble Burst? Motley Fool
Aug-26-20 10:00AM	Why Heat Biologics Stock Is Popping Today Motley Fool
07:30AM	Heat Biologics Announces Publication of Preclinical COVID-19 Vaccine Results ACCESSWIRE
Aug-24-20 11:14AM	Why Heat Biologics, Inovio Pharmaceuticals, and Novavax Are Getting Clobbered Today Motley Fool -13.04%
Aug-13-20 01:54PM	Why Heat Biologics Stock Surged Today Motley Fool +17.31%
08:18AM	The Daily Biotech Pulse: Mesoblast Awaits Adcom Test, BioCryst Rallies On Insider Buying, Sorrento Hits Back At Short Seller Benzinga
07:00AM	Heat Biologic's COVID-19 Vaccine Demonstrates Robust T Cell Driven Immune Response to SARS-CoV-2 in Preclinical Studies ACCESSWIRE
Aug-12-20 12:47PM	Why Novavax, Vaxart, Sorrento Therapeutics, and Other Coronavirus Stocks Plummeted Today Motley Fool -15.68%
Aug-11-20 11:27AM	Why Dynavax Technologies, Heat Biologics, and Inovio Pharmaceuticals Are Cratering Today Motley Fool -12.32%
Aug-07-20 07:00AM	Heat Biologics Provides Second Quarter 2020 Business Update ACCESSWIRE
Aug-05-20 07:30AM	Heat Biologics Highlights Importance of T cell Immunity to Prevent COVID-19 ACCESSWIRE
Aug-03-20 10:00AM	2 Risky Coronavirus Vaccine Stocks That Could Make You Filthy Rich Motley Fool
Jul-30-20 09:07AM	Heat Biologics, Inc. (NASDAQ:HTBX) Analysts Just Slashed This Year's Revenue Estimates By 12% Simply Wall St.
Jul-29-20 12:05PM	Why Heat Biologics Stock Is Spiking Today Motley Fool +7.73%
07:30AM	Heat Biologics COVID-19 Vaccine Demonstrates Immunogenicity Proof-of-Concept in Pre-Clinical Studies ACCESSWIRE
Jul-27-20 06:30AM	Heat Biologics Regains Compliance with Nasdaq Minimum Bid Price Rule ACCESSWIRE -5.98%
Jun-22-20 10:54AM	Why Heat Biologics Stock Is Trading Higher Today Benzinga
07:30AM	Heat Biologics Announces First Patient Treated in First-in-Human Clinical Trial of PTX-35 ACCESSWIRE
Jun-20-20 09:49AM	Newsflash: Heat Biologics, Inc. (NASDAQ:HTBX) Analysts Have Been Trimming Their Revenue Forecasts Simply Wall St.
Jun-18-20 07:30AM	Heat Biologics Announces Initiation of the Lead Clinical Trial Site for PTX-35 ACCESSWIRE +6.40%
Jun-08-20 07:30AM	Heat Biologics Announces FDA Clearance of Investigational New Drug (IND) Application for PTX-35 ACCESSWIRE
Jun-04-20 07:30AM	Heat Biologics Provides Update on COVID-19 Vaccine Efforts ACCESSWIRE +6.72%
Jun-01-20 06:15AM	HTBX: The Antigen Chaperone: gp96 Zacks Small Cap Research -10.19%
May-29-20 08:00AM	Heat Biologics Presents Positive Survival Benefit for HS-110 in Combination with Nivolumab in Phase 2 Lung Cancer Trial at 2020 American Society of Clinical Oncology (ASCO) Annual Meeting ACCESSWIRE -8.11%
May-28-20 11:34AM	ER doctor: 12-18 month coronavirus vaccine timeline 'is extremely optimistic' Yahoo Finance +14.91%
May-27-20 08:00AM	Heat Biologics Announces Collaboration with Waisman Biomanufacturing to Manufacture COVID-19 Vaccine ACCESSWIRE
May-18-20 07:45AM	We're Keeping An Eye On Heat Biologics's (NASDAQ:HTBX) Cash Burn Rate Simply Wall St.
May-15-20 09:30AM	Heat Biologics Provides First Quarter 2020 Business Update ACCESSWIRE
May-14-20 08:00AM	Positive Survival Data from Phase 2 Lung Cancer Trial Accepted for Presentation at 2020 American Society of Clinical Oncology (ASCO) Annual Meeting ACCESSWIRE
May-11-20 08:00AM	Heat Biologics Provides Clinical Update; Reports Continued Progress Advancing HS-110 ACCESSWIRE +5.88%
Apr-29-20 08:37AM	Heat Biologics Reports Progress on COVID-19 Efforts and Timeline of Anticipated Q2 2020 Milestones ACCESSWIRE
Apr-13-20 03:27PM	Coronavirus: Trump retweets call to fire Fauci Yahoo Finance Video +12.04%
Apr-09-20 03:45PM	HTBX: $25M in Cash to Advance Portfolio Zacks Small Cap Research +7.02%
12:57PM	These 20 companies are working on coronavirus treatments or vaccines heres where things stand MarketWatch
Apr-01-20 08:00AM	Heat Biologics Announces Formation of COVID-19 Advisory Board ACCESSWIRE -6.91%
Mar-30-20 08:30AM	Heat Biologics Provides Year-End Business Update ACCESSWIRE
Mar-23-20 02:38PM	Morrisville firm developing coronavirus test that produces results in 30 minutes American City Business Journals
09:00AM	Heat Biologics and University of Miami Developing Proprietary COVID-19 Diagnostic Test Under Collaborative Research Agreement ACCESSWIRE
Mar-17-20 02:35PM	Shares of Heat Biologics rise on plans to develop COVID-19 vaccine candidate MarketWatch +16.04%
Mar-16-20 08:00AM	Heat Biologics Invited to Join The Alliance for Biosecurity ACCESSWIRE +10.64%
Mar-11-20 09:23AM	Biotech Maven Hal Mintz Snaps Up These 3 Small Biotech Stocks TipRanks +16.65%
Mar-09-20 10:55AM	On the Back of Possible Coronavirus Vaccine, Analyst Sees Over 170% Upside for Heat Biologics TipRanks +5.31%
Mar-06-20 01:52PM	TBJ Plus: Coronavirus threatens ACC Tournament, hurts Raleigh restaurants; Reynolds mansion still unsold; Peek inside this new brewery American City Business Journals -15.52%
Mar-05-20 04:45PM	Heat Biologics, Inc. to Present at the Spring Investor Summit on March 25th-26th in New York City ACCESSWIRE +18.29%
09:00AM	Heat Biologics Announces Research Collaboration with University of Miami to Develop Vaccine Designed to Protect Against COVID-19 Coronavirus ACCESSWIRE
Mar-04-20 03:10PM	Heat Biologics CEO to Appear Today on ABC11-WTVD to Discuss the Companys Newly Launched Program to Develop a Vaccine to Protect Against SARS-CoV-2 Coronavirus that Causes COVID-19 ACCESSWIRE +35.92%
09:48AM	3 Biotech Stocks Join the Coronavirus Fight TipRanks
Mar-03-20 02:41PM	Morrisville company joins race for coronavirus vaccine American City Business Journals -24.59%
08:00AM	Benzinga Pro's Top 6 Stocks To Watch For Tues., Mar. 3, 2020: TGT, BYND, UBER, NOVN, QRVO, HTBX Benzinga
08:00AM	Heat Biologics Launches Program to Develop Vaccine Designed to Protect Against COVID-19 Coronavirus ACCESSWIRE
Feb-28-20 02:15PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Heat Biologics, Inc.- HTBX ACCESSWIRE +54.93%
Feb-24-20 02:59PM	Advance Auto Parts, Cree among Triangle companies hit as stocks tumble with rising concern over coronavirus American City Business Journals
Jan-21-20 04:05PM	Heat Biologics, Inc. Announces Closing of $7,000,000 Public Offering ACCESSWIRE
Jan-16-20 09:50AM	Heat Biologics, Inc. Prices $7,000,000 Public Offering ACCESSWIRE -24.36%
Jan-15-20 02:33PM	Triangle drugmaker preps for public offering American City Business Journals
Dec-23-19 08:39AM	Here's What We Think About Heat Biologics, Inc.'s (NASDAQ:HTBX) CEO Pay Simply Wall St.
Dec-16-19 07:00AM	Heat Biologics Announces First Patient Dosed in the First Phase 1 Trial of HS-130 ACCESSWIRE
Nov-29-19 05:05AM	HTBX: Third Quarter 2019 Results Zacks Small Cap Research
Nov-20-19 08:00AM	Heat Biologics Announces Additional Positive Top Line Phase 2 Data of HS-110 plus Nivolumab in Advanced NSCLC Patients ACCESSWIRE -10.21%
Nov-19-19 07:56AM	The Daily Biotech Pulse: Therapix To Reverse Merge With CBD Company, Crispr Gene Editing Therapy Readout Benzinga +21.84%
Nov-18-19 08:00AM	Heat Biologics Announces Additional Top Line Phase 2 Data of HS-110 plus Nivolumab in Advanced NSCLC Patients at AACR Tumor Immunology and Immunotherapy Conference ACCESSWIRE
Nov-15-19 08:30AM	Heat Biologics Reports Third Quarter 2019 Results and Provides Corporate Update ACCESSWIRE
Nov-11-19 07:00AM	Heat Biologics Presents Additional Phase 2 Interim Data in Advanced NSCLC Patients at the SITC 34th Annual Meeting ACCESSWIRE -8.69%
Nov-08-19 08:14AM	The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera's Reverse Split, 2 Biotechs To Debut Benzinga
Nov-07-19 08:02AM	We Think Heat Biologics (NASDAQ:HTBX) Needs To Drive Business Growth Carefully Simply Wall St. -8.18%
Nov-05-19 08:00AM	Heat Biologics Reports Positive Phase 2 Interim Data in NSCLC Patients Who Previously Failed Checkpoint Inhibitor Treatment ACCESSWIRE -13.13%
Oct-24-19 09:00AM	Heat Biologics Announces a Poster Presentation of Updated Top Line Phase 2 Data of HS-110 plus Nivolumab after Checkpoint Inhibitor Treatment Failure in NSCLC Patients at the SITC 34th Annual Meeting ACCESSWIRE +8.99%
Oct-02-19 09:23AM	What Kind Of Shareholders Own Heat Biologics, Inc. (NASDAQ:HTBX)? Simply Wall St.
Aug-27-19 08:44AM	Introducing Heat Biologics (NASDAQ:HTBX), The Stock That Collapsed 99% Simply Wall St.
Aug-26-19 12:30PM	HTBX: HS-130 Ready To Go Zacks Small Cap Research
Aug-24-19 01:46PM	10 Biopharmaceutical Companies Trying To Cure Cancer Benzinga
Aug-14-19 07:00AM	Heat Biologics Reports Second Quarter 2019 Results and Provides Corporate Update ACCESSWIRE -6.57%
Aug-12-19 07:00AM	Heat Biologics Announces FDA Clearance of IND Application to Begin Phase 1 Trial of HS-130 in Combination with Heats HS-110 ACCESSWIRE
Aug-07-19 11:15AM	Heat Biologics CEO and Lead Director to Participate in German Investor Forums ACCESSWIRE -7.46%
Jul-10-19 02:41PM	What You Must Know About Heat Biologics, Inc.'s (NASDAQ:HTBX) Beta Value Simply Wall St.
Jul-09-19 08:00AM	Heat Biologics Completes Enrollment in Phase 2 Non-Small Cell Lung Cancer Trial ACCESSWIRE
Jun-12-19 01:30PM	HTBX: INDs To Be Filed Soon Zacks Small Cap Research
Jun-03-19 06:55AM	Heat Biologics Announces Promising Interim Phase 2 Lung Cancer Data Suggesting that HS-110 Plus Nivolumab May Restore Clinical Benefit After Checkpoint Inhibitor Treatment Failure ACCESSWIRE +7.89%
May-23-19 11:09AM	Is Heat Biologics, Inc.'s (NASDAQ:HTBX) CEO Overpaid Relative To Its Peers? Simply Wall St. -12.52%
May-20-19 08:30AM	Heat Biologics to Present at the 20th Annual B. Riley FBR Institutional Investor Conference ACCESSWIRE -5.22%
May-15-19 07:30AM	Heat Biologics Reports First Quarter 2019 Results and Provides Corporate Update ACCESSWIRE
May-06-19 07:00AM	Heat Biologics Lead Director to Present at the ChinaBio 2019 Conference in Shanghai ACCESSWIRE
Apr-18-19 05:30PM	Heat Biologics CEO to Present at the ThinkEquity Conference in New York City ACCESSWIRE
Apr-11-19 09:30AM	HTBX: 2018 Financial & Operational Results Zacks Small Cap Research
Apr-02-19 08:00AM	Heat Biologics Delivers Poster Presentation at the AACR Annual Meeting 2019 ACCESSWIRE
Mar-28-19 07:30AM	Heat Biologics Reports 2018 Results and Provides Corporate Update ACCESSWIRE

Heat Biologics, Inc., a biopharmaceutical company, focuses on developing immunotherapies to activate patient's immune system against cancer through T-cell activation and expansion. The company's T-cell activation platform, includes two variations for intradermal administration, such as immune pan-antigen cytotoxic therapy, an allogenic cell-based, T-cell-stimulating platform that functions as an immune activator to stimulate and expand T-cells; and combination pan-antigen cytotoxic therapy, a dual-acting immunotherapy, which delivers antigen driven T-cell activation and specific co-stimulation in a single product. It is developing HS-110, which is in phase II clinical trials to treat patients with advanced non-small cell lung cancer. The company's preclinical stage products include HS-130 for the treatment of advanced solid tumors; PTX-35, a humanized affinity matured monoclonal antibody, which is a functional agonist of human TNFRSF25 signaling; and PTX-45, a human TL1A-Ig fusion protein that acts as an agonist of TNFRSF25 signaling. Heat Biologics, Inc. has collaboration with Waisman Biomanufacturing to manufacture COVID-19 Vaccine. The company was founded in 2008 and is headquartered in Morrisville, North Carolina.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Smith Edward B III	Director	Nov 12	Sale	1.03	103,304	106,403	0	Nov 13 05:31 PM
Ostrander William L.	VP Finance/Corp Secy	Aug 13	Option Exercise	0.52	15,625	8,125	15,625	Aug 14 06:01 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience